Letters in Drug Design & Discovery
Volume 17, 12 Issues, 2020
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
This journal supports open access
Ranking and Category
-
57th of 61 in
Chemistry, Medicinal
Contents
Letters in Drug Design & Discovery, Volume 2 - Number 8
Rational Design of the New Antihypertensive I1-Receptor Ligand 2-(2- Biphenyl-2-yl-1-methyl-ethyl)-4,5-dihydro-1H-imidazole
, 2(8): 571 - 578F. Gentili, P. Bousquet, A. Carrieri, J. Feldman, F. Ghelfi, M. Giannella, A. Piergentili, W. Quaglia, C. Vesprini and M. Pigini
DOI: 10.2174/157018005774717325
Docking Study, Synthesis and SAH-Hydrolase Inhibitory Activity of LAdeninylalanine and Related Analogues
, 2(8): 579 - 583Nicolas Floquet, Samuel Leroy, Murielle Muzard, Georges Guillerm and Jean-Bernard Behr
DOI: 10.2174/157018005774717262
Anti-tumour Activity of Some Polydentate N-Ligands: N,N-bis-(3- Substituted-5-Methylpyrazol-1yl Methyl) Arylamines and N,N,N,N-Tetra- [(3-Substituted-5-Methylpyrazol-1yl] Para-Phenylenediamines
, 2(8): 584 - 589T. B. Hadda, A. T. Kotchevar, M. Daoudi, B. Bennani, N. B. Larbi and A. Kerbal
DOI: 10.2174/157018005774717299
Discovery of Thrombin Inhibitor Fragments from Chemical Microarray Screening
, 2(8): 590 - 594Thomas Neumann, Hans-Dieter Junker, Oliver Keil, Klaus Burkert, Holger Ottleben, Jurgen Gamer, Renate Sekul, Holger Deppe, Achim Feurer, Dirk Tomandl and Gunther Metz
DOI: 10.2174/157018005774717343
Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition
, 2(8): 595 - 600Nicolas Pietrancosta, Gilles Quelever, Cedrik Garino, Younes Laras, Stephane Burlet and Jean-Louis Kraus
DOI: 10.2174/157018005774717352
Synthesis and Biological Evaluation of 1,2,4-Triazolo[2,3-a]pyrrole Derivatives as Alpha-4 ( α4) Integrin Antagonists
, 2(8): 601 - 605Edward C. Lawson, William A. Kinney, Rosemary J. Santulli, Carol M. Fisher, Bruce P. Damiano and Bruce E. Maryanoff
DOI: 10.2174/157018005774717280
Szeged Index - Applications for Drug Modeling&#
, 2(8): 606 - 624Padmakar V. Khadikar, Sneha Karmarkar, Vijay K. Agrawal, Jyoti Singh, Anjali Shrivastava, Istvan Lukovits and Mircea V. Diudea
DOI: 10.2174/157018005774717334
Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification
, 2(8): 625 - 630Gregory S. Bisacchi, Philip D. Stein, Jack Z. Gougoutas, Karen S. Hartl, R. Michael Lawrence, Eddie Liu, Andrew Pudzianowski, William A. Schumacher, Doree Sitkoff, Thomas E. Steinbacher, James Sutton, Zhaoxiao Zhang and Steven M. Seiler
DOI: 10.2174/157018005774717316
Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy
, 2(8): 631 - 637Damien Combaud, Mickael Thomas, Sebastien Papot and Jean-Pierre Gesson
DOI: 10.2174/157018005774717271
Structure Based Design of Inhibitors of Aspartic Protease of HIV-1
, 2(8): 638 - 646V. Frecer, A. Jedinak, A. Tossi, F. Berti, F. Benedetti, D. Romeo and S. Miertus
DOI: 10.2174/157018005774717307
  |
Editor-in-Chief
K. Kuca
University of Hradec Kralove
Hradec Kralove
Czech Republic
Biography
View Full Editorial Board
University of Hradec Kralove
Hradec Kralove
Czech Republic
Biography
Biography of K. Kuca
Kamil Kuca is working for several academic institutes (University of Hradec Kralove, Czech Republic; University Hospital Hradec Kralove, Czech republic; Florida International University, USA; Yangtze University, China; etc.). He is recently rector of the University of Hradec Kralove. He was also technology scout focused on biomedicine in the past. His research interests are toxicology, pharmacology, drug design, technology transfer, pharmacoeconomy, chemical and biological terrorism, etc. He was/is principal investigator on numerous national and international projects (EU, NATO, GACR, IGA MZ, MSMT etc.). He has published more than 350 IF research papers. He is working with several companies as a scientific consultant. He has lots of cooperators throughout the world (e.g. Korea, Croatia, United Arab Emirates, USA, France, Turkey, China, Singapore, Sweden, and Brazil). His Hindex is 36, number of citation in WoS is over 3000.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Letters in Drug Design & Discovery was introduced in 2004. Dr. Kamil Kuca serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.05
Advertisement
Webmaster Contact: info@benthamscience.net